Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
Ozempic, Wegovy introduced in Kenya as diabetes, obesity burden grows
The introduction of Ozempic and Wegovy in Kenya is drawing attention to the country’s growing cardio-metabolic health burden, as healthcare experts call for a more comprehensive approach to the…
Childhood Cancer Canada calls for $15M from feds as demand rises
Childhood Cancer Canada says demand for its financial support programs has risen 40 per cent in two years as families face the long-term costs of a diagnosis.
Childhood Cancer Canada calls for $15M from feds as demand rises
Childhood Cancer Canada says demand for its financial support programs has risen 40 per cent in two years as families face the long-term costs of a diagnosis.
Predicting Preeclampsia With a Protein? Gene-Silencing for Cardiomyopathy
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of…
Pregnancy diabetes linked to type 2 diabetes 13 years earlier
Pregnancy diabetes may disappear after childbirth, but its shadow can stretch far into a woman’s future.
When cancer enters a home, no one should face it alone
A cancer diagnosis rarely affects one person alone. It enters a home, sits beside relatives and follows families long after the hospital appointment ends.